Anzeige
Mehr »
Freitag, 28.08.2026 - Börsentäglich über 12.000 News
Vom Forschungstrend zum Milliardenmarkt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40KHL | ISIN: US64113L2025 | Ticker-Symbol:
NASDAQ
27.08.26 | 22:00
0,539 US-Dollar
0,00 % 0,000
1-Jahres-Chart
NETCAPITAL INC Chart 1 Jahr
5-Tage-Chart
NETCAPITAL INC 5-Tage-Chart

Aktueller Chart NETCAPITAL Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
NETCAPITAL INC-Investoren interessieren sich auch für diese Wertpapiere
Sonoma Pharmaceuticals: Historischer Wendepunkt - darum fliegt die Aktie!Volltreffer: Bereits im Frühjahr hatte ich die positive Entwicklung bei Sonoma Pharmaceuticals antizipiert und die Nano-Cap-Aktie als hochinteressante Turnaround-Spekulation vorgestellt. Damals hatte...
► Artikel lesen
Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDATotal revenue increased 60% year over year to $6.4 millionNet loss per share decreased 88% compared to the prior-year quarterGross margin expanded to 40% as operating expenses remained stableFDA clearance...
► Artikel lesen
Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn Wound Irrigation SolutionBOULDER, CO / ACCESS Newswire / June 30, 2026 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced it has received a new 510(k)...
► Artikel lesen
Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): Under ReviewOriginal-Research: Jaguar Health Inc - from First Berlin Equity Research GmbH 28.08.2026 / 14:44 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group. The issuer...
► Artikel lesen
Jaguar Health, Inc.: Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in DogsNeonorm Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI...
► Artikel lesen
Jaguar Health, Inc.: Jaguar Health Reports Second Quarter 2026 FinancialsCompany remains sharply focused on its ongoing global development program for crofelemer for rare intestinal failure (IF) diseases; as announced, presentation at ESPGHAN 2026 described additional groundbreaking...
► Artikel lesen
QXO, Inc. Completes Acquisition of TopBuild Corp.Deal Expected to Be Substantially Accretive to QXO's Earnings GREENWICH, Conn.--(BUSINESS WIRE)--QXO, Inc. (NYSE: QXO) today announced it has closed its previously disclosed acquisition of TopBuild...
► Artikel lesen
QXO, Inc. and TopBuild Corp. Stockholders Overwhelmingly Approve QXO's Acquisition of TopBuildGREENWICH, Conn. & DAYTONA BEACH, Fla.--(BUSINESS WIRE)--QXO, Inc. (NYSE: QXO) ("QXO") and TopBuild Corp. (NYSE: BLD) ("TopBuild") today announced that stockholders of both companies overwhelmingly...
► Artikel lesen
Jacobs hat ganze Branchen aufgemischt: Ist QXO der nächste Coup?Brad Jacobs hat mehrfach bewiesen, wie man in zersplitterten Märkten dominante Konzerne formt. Ist QXO der nächste Coup Den vollständigen Artikel lesen ...
► Artikel lesen